Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive congenital ichthyosis in which the cause of the disease is a mutation in the LIPN gene.
Features include always present findings: Dry, scaly skin (ichthyosis), Hypergranulosis, Epidermal acanthosis, and Orthokeratosis and others. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 3 | Dry, scaly skin (ichthyosis), Erythema, Thickened, rough skin (hyperkeratosis) |
LIPN encodes lipase family member N (398 aa). Plays a highly specific role in the last step of keratinocyte differentiation. Highest expression in Skin Not Sun Exposed Suprapubic (16.6 TPM) and Skin Sun Exposed Lower leg (12.6 TPM).
Autosomal recessive congenital ichthyosis 8 is associated with mutations in the LIPN gene on chromosome 10.
LIPN is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for LIPN is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive congenital ichthyosis 8 has been reported in the published literature.
Phenotype severity distribution: 5 always present features.
No clinical trials have been registered for autosomal recessive congenital ichthyosis 8.
16 publications have been identified in PubMed for autosomal recessive congenital ichthyosis 8. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 44% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:50 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Research summaries
3 |
19% |
Laboratory research | 2 | 13% |
Disease patterns and progression | 2 | 13% |
Other research | 1 | 6% |
Testing and diagnosis research | 1 | 6% |
Elgie T (2026). [PMID: 42001132](https://pubmed.ncbi.nlm.nih.gov/42001132/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Luboń W (2026). [PMID: 42072832](https://pubmed.ncbi.nlm.nih.gov/42072832/). *Diagnostics (Basel)*. [Diagnostic / Biomarker]
Lixiang W (2025). [PMID: 41062103](https://pubmed.ncbi.nlm.nih.gov/41062103/). *J Int Med Res*. [Case Report / Case Series]
Li GX (2025). [PMID: 40000070](https://pubmed.ncbi.nlm.nih.gov/40000070/). *Pediatr Dermatol*. [Review / Meta-Analysis]
Dodeja A (2025). [PMID: 40212506](https://pubmed.ncbi.nlm.nih.gov/40212506/). *J Orthop Case Rep*. [Case Report / Case Series]
Xiang R (2025). [PMID: 40709761](https://pubmed.ncbi.nlm.nih.gov/40709761/). *Acta Derm Venereol*. [Review / Meta-Analysis]
Johar R (2025). [PMID: 40607310](https://pubmed.ncbi.nlm.nih.gov/40607310/). *J Allergy Clin Immunol Glob*. [Case Report / Case Series]
Maarouf S (2025). [PMID: 39659087](https://pubmed.ncbi.nlm.nih.gov/39659087/). *Pediatr Dermatol*. [Review / Meta-Analysis]
Sefer AP (2025). [PMID: 41346588](https://pubmed.ncbi.nlm.nih.gov/41346588/). *Front Immunol*. [Epidemiology / Natural History]
Chang TY (2025). [PMID: 39794051](https://pubmed.ncbi.nlm.nih.gov/39794051/). *Taiwan J Obstet Gynecol*. [Case Report / Case Series]